Johnson, N <br/><br/>
Pre-clinical evaluation of cyclin-dependent kinase 2 and 1 inhibition in anti-estrogen-sensitive and resistant breast cancer cells.  [electronic resource] 

 -  British journal of cancer  Jan 2010 
 - 342-50 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1532-1827 
<br/><br/><label>Standard No.: </label>10.1038/sj.bjc.6605479  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Breast Neoplasms<br/>CDC2 Protein Kinase--metabolism<br/>Cell Cycle--drug effects<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cyclin-Dependent Kinase 2--metabolism<br/>Estrogen Receptor Modulators--pharmacology<br/>Female<br/>Humans<br/>Protein Kinase Inhibitors--pharmacology